Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q418546> ?p ?o }
Showing triples 1 to 77 of
77
with 100 triples per page.
- Q418546 subject Q8412954.
- Q418546 subject Q8824839.
- Q418546 subject Q8852204.
- Q418546 subject Q9216848.
- Q418546 abstract "Aztreonam (trade names Azactam injection, Cayston inhalation) is a monobactam antibiotic used primarily to treat infections caused by gram-negative bacteria. It is a synthetic drug based on a simpler monobactam isolated from Chromobacterium violaceum. It is resistant to some beta-lactamases, but is inactivated by extended-spectrum beta-lactamases. It was approved by the U.S. Food and Drug Administration (FDA) in 1986.".
- Q418546 atcPrefix "J01".
- Q418546 atcSuffix "DF01".
- Q418546 bioavailability "100.0".
- Q418546 casNumber "78110-38-0".
- Q418546 chEBI "161680".
- Q418546 drugbank "DB00355".
- Q418546 fdaUniiCode "G2B4VE5GH8".
- Q418546 iupacName "2-({[(1Z)-1-(2-amino-1,3-thiazol-4-yl) -2- {[(2S,3S)-2-methyl-4-oxo-1-sulfoazetidin-3-yl]amino} -2- oxoethylidene]amino}oxy)-2-methylpropanoic acid".
- Q418546 pubchem "54116".
- Q418546 thumbnail Aztreonam_structure.svg?width=300.
- Q418546 wikiPageWikiLink Q12187.
- Q418546 wikiPageWikiLink Q12190.
- Q418546 wikiPageWikiLink Q127076.
- Q418546 wikiPageWikiLink Q131271.
- Q418546 wikiPageWikiLink Q131854.
- Q418546 wikiPageWikiLink Q132229.
- Q418546 wikiPageWikiLink Q134081.
- Q418546 wikiPageWikiLink Q134281.
- Q418546 wikiPageWikiLink Q134980.
- Q418546 wikiPageWikiLink Q142705.
- Q418546 wikiPageWikiLink Q1758380.
- Q418546 wikiPageWikiLink Q178194.
- Q418546 wikiPageWikiLink Q186889.
- Q418546 wikiPageWikiLink Q1878682.
- Q418546 wikiPageWikiLink Q188121.
- Q418546 wikiPageWikiLink Q189790.
- Q418546 wikiPageWikiLink Q199695.
- Q418546 wikiPageWikiLink Q204711.
- Q418546 wikiPageWikiLink Q2281580.
- Q418546 wikiPageWikiLink Q25419.
- Q418546 wikiPageWikiLink Q2697755.
- Q418546 wikiPageWikiLink Q271021.
- Q418546 wikiPageWikiLink Q30.
- Q418546 wikiPageWikiLink Q311273.
- Q418546 wikiPageWikiLink Q311275.
- Q418546 wikiPageWikiLink Q311379.
- Q418546 wikiPageWikiLink Q31856.
- Q418546 wikiPageWikiLink Q3498295.
- Q418546 wikiPageWikiLink Q408.
- Q418546 wikiPageWikiLink Q40878.
- Q418546 wikiPageWikiLink Q417315.
- Q418546 wikiPageWikiLink Q432083.
- Q418546 wikiPageWikiLink Q4784668.
- Q418546 wikiPageWikiLink Q505142.
- Q418546 wikiPageWikiLink Q632006.
- Q418546 wikiPageWikiLink Q640448.
- Q418546 wikiPageWikiLink Q653197.
- Q418546 wikiPageWikiLink Q7162855.
- Q418546 wikiPageWikiLink Q840343.
- Q418546 wikiPageWikiLink Q8412954.
- Q418546 wikiPageWikiLink Q857288.
- Q418546 wikiPageWikiLink Q8824839.
- Q418546 wikiPageWikiLink Q8852204.
- Q418546 wikiPageWikiLink Q9216848.
- Q418546 wikiPageWikiLink Q9377.
- Q418546 atcPrefix "J01".
- Q418546 atcSuffix "DF01".
- Q418546 bioavailability "100".
- Q418546 casNumber "78110".
- Q418546 chebi "161680".
- Q418546 drugbank "DB00355".
- Q418546 iupacName "2".
- Q418546 pubchem "54116".
- Q418546 unii "G2B4VE5GH8".
- Q418546 type ChemicalSubstance.
- Q418546 type Drug.
- Q418546 type ChemicalObject.
- Q418546 type Thing.
- Q418546 type Q8386.
- Q418546 comment "Aztreonam (trade names Azactam injection, Cayston inhalation) is a monobactam antibiotic used primarily to treat infections caused by gram-negative bacteria. It is a synthetic drug based on a simpler monobactam isolated from Chromobacterium violaceum. It is resistant to some beta-lactamases, but is inactivated by extended-spectrum beta-lactamases. It was approved by the U.S. Food and Drug Administration (FDA) in 1986.".
- Q418546 label "Aztreonam".
- Q418546 depiction Aztreonam_structure.svg.